Associated Papers
Genetic variations in AAK1 and ADAM17 associated with circulatory cytokines changes influence COVID-19 susceptibility and severity.
Bouzid A et al.
Human Genomics, 2026
The -172 A-to-G variation in ADAM17 gene promoter region affects EGR1/ADAM17 pathway and confers susceptibility to septic mortality with sepsis-3.0 criteria.
He J et al.
International Immunopharmacology, 2022
Association Study Between Promoter Polymorphisms of ADAM17 and Progression of Sepsis.
Shao Y et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2016
Select a paper to view details